Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Novartis erzielte im ersten Quartal mit prioritären Marken und Neueinführungen ein starkes Wachstum; Prognose für das Geschäftsjahr 2026 bekräftigt

globenewswire.com
NVS

BioNJ Announces Lineup for BioPartnering Conference

prnewswire.com
BMY FER JNJ MRK NVS PFE TEVA

Union Pacific Recognizes 138 Companies with Pinnacle Award for Safely Shipping Hazardous Materials

businesswire.com
UNP ADM AVT BG CE CF CL CTVA DD DOW DVN ECL EM EQT XOM FCX HOG HPE HRI HVT ICE IFF INV IVZ JCI JNJ KMB KO LIN LPCN LYB MDT MEOH MGM MMC MMM MO MSFT NKE NOC NOV NVR NVS NVO NXT OIS OKE OLN OMC ORCL ORLY OSK OTIS OVV OXM OXY PAG PAHC PAR PCAR PEG PEP PFG PGR PH PHG PII PLD PM PNC PNW PPG PPL PRGO PRU PSA PSX PVH PWR PX PYPL QCOM RCL RDN REG RF RHI RIVN RL RMD RNR ROK ROL ROST RRC RS RTX S SABR SAN SBUX SCHW SEE SEIC SHW SI SIBN SIG SIRI SITE SLB SMG SNA SNOW SNY SO SON SONO SPG SPGI SPRO SQM SRG SSNC ST STAG STE STG STI STLD STNG STX STZ SUI SUN SW SWK SWX SY SYK SYY T TAC TAL TBBK TCI TD TDC TDG TDOC TECK TEF TEL TEN TER TEX TFC TFX TGT THC THO TJX TKR TLRY TMO TNC TNK TNL TOL TOPS TORO TPB TPG TPH TR TRC TRI TRMB TRN TROX TRP TRS TRT TRV TS TSLA TTC TTI TTWO TV TW TWIN TWLO TX TXN TXT TYL TZOO U UAA UAL UAN UDR UEC UFPI UG UHAL UHS UL ULTA UMC UMH UNF UNH UNIT UNM UONE URBN USFD USNA USPH UTHR UTL UVV V VAL VALE VRTX VTR W WAB WBS WCC WCN WDC WEC WEN WFC WFG WGO WHD WHR WMB WMG WMT WPC WPP WRLD WRN WSBC WSC WSFS WST WTFC WTI WTS WU WVE WWD WWW XCUR XPO XRAY XRX XYL YETI YMM YUM Z ZBH ZBRA ZION ZNTL ZTS

Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria

globenewswire.com
NVS

Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, Pfizer, Sanofi, Takeda, Novartis, Johnson & Johnson, Roche, Biocon Biologics

globenewswire.com
AKBA GSK VRTX PFE SNY NVS JNJ

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)

globenewswire.com
NVS

Oncology Clinical Trials Research Report 2026: $20+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
PFE JNJ MRK ABBV NVS CHRS

Rare Disease Clinical Trials Research Report 2026: $21.34 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
AZN PFE NVS

Ribonucleic Acid (RNA) Therapy Clinical Trials Research Report 2026: $3.4 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
PFE AZN NVS GSK MRNA

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants

globenewswire.com
NVS